88 related articles for article (PubMed ID: 31361606)
1. Prechemotherapy Hemoglobin Levels as a Predictive Factor of Ovarian Cancer Survival: A Systematic Review and Meta-Analysis.
Pergialiotis V; Daskalakis G; Thomakos N; Bellos I; Haidopoulos D; Loutradis D; Rodolakis A
Am J Clin Oncol; 2019 Sep; 42(9):725-731. PubMed ID: 31361606
[TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
Wu YS; Shui L; Shen D; Chen X
Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer.
Eichbaum MH; Weiss LM; Bruckner T; Schneeweiss A; Sinn HP; Gebauer G; Fersis N; Kussmaul J; Sohn C
Med Sci Monit; 2009 Apr; 15(4):CR156-63. PubMed ID: 19333199
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of bevacizumab combined with chemotherapy in the treatment of ovarian cancer.
Wang TS; Lei W; Cui W; Wen P; Guo HF; Ding SG; Yang YP; Xu YQ; Lv SW; Zhu YL
Indian J Cancer; 2014 Mar; 51 Suppl 3():e95-8. PubMed ID: 25818743
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Accuracy of Human Epididymis Factor 4 for the Prediction of Optimal Debulking in Patients With Ovarian Cancer: A Meta-Analysis of Observational Studies.
Pergialiotis V; Karampetsou N; Bellos I; Thomakos N; Daskalakis G
Int J Gynecol Cancer; 2018 Oct; 28(8):1471-1477. PubMed ID: 30036230
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
8. Maintenance chemotherapy for ovarian cancer.
Mei L; Chen H; Wei DM; Fang F; Liu GJ; Xie HY; Wang X; Zou J; Han X; Feng D
Cochrane Database Syst Rev; 2010 Sep; (9):CD007414. PubMed ID: 20824860
[TBL] [Abstract][Full Text] [Related]
9. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P
Cochrane Database Syst Rev; 2008 Oct; (4):CD006014. PubMed ID: 18843699
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients.
Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
Int J Gynecol Cancer; 2011 Aug; 21(6):1040-7. PubMed ID: 21738039
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review.
Pergialiotis V; Nikolaou C; Haidopoulos D; Frountzas M; Thomakos N; Bellos I; Papapanagiotou A; Rodolakis A
Acta Cytol; 2020; 64(6):547-555. PubMed ID: 32683364
[TBL] [Abstract][Full Text] [Related]
12. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
13. Perioperative blood transfusion and ovarian cancer survival rates: A meta-analysis based on univariate, multivariate and propensity score matched data.
Pergialiotis V; Thomakos N; Frountzas M; Haidopoulos D; Loutradis D; Rodolakis A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():137-143. PubMed ID: 32603932
[TBL] [Abstract][Full Text] [Related]
14. Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Colombo N; Fanucchi A; Chiudinelli F; Lapresa M; Maria Ferrero A
Gynecol Oncol; 2005 Jul; 98(1):118-23. PubMed ID: 15913740
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
[TBL] [Abstract][Full Text] [Related]
16. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Underweight Status on the Prognosis of Ovarian Cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract][Full Text] [Related]
18. Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trials.
Marchetti C; De Felice F; Di Pinto A; D'Oria O; Aleksa N; Musella A; Palaia I; Muzii L; Tombolini V; Benedetti Panici P
Crit Rev Oncol Hematol; 2018 May; 125():30-34. PubMed ID: 29650273
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies.
Zhang D; Zhao Y; Wang T; Xi Y; Li N; Huang H
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27860198
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of Müllerian Origin Treated With Neoadjuvant Chemotherapy.
Mahdi H; Maurer KA; Nutter B; Rose PG
Int J Gynecol Cancer; 2015 Jun; 25(5):823-9. PubMed ID: 25828750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
